GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Additional Paid-In Capital

Labiana Health (XMAD:LAB) Additional Paid-In Capital : €8.20 Mil(As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Additional Paid-In Capital?


Labiana Health's quarterly additional paid-in capital increased from Dec. 2021 (€3.14 Mil) to Jun. 2022 (€8.20 Mil) but then stayed the same from Jun. 2022 (€8.20 Mil) to Dec. 2022 (€8.20 Mil).

Labiana Health's annual additional paid-in capital stayed the same from Dec. 2020 (€3.14 Mil) to Dec. 2021 (€3.14 Mil) but then increased from Dec. 2021 (€3.14 Mil) to Dec. 2022 (€8.20 Mil).


Labiana Health Additional Paid-In Capital Historical Data

The historical data trend for Labiana Health's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Additional Paid-In Capital Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Additional Paid-In Capital
3.14 3.14 8.20

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Additional Paid-In Capital 3.14 3.14 8.20 8.20

Labiana Health Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Labiana Health Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Labiana Health's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.